ES465034A1 - Procedimiento para la preparacion de derivados de acidos n- (benzotiazol-2-il)-oxamidicos. - Google Patents

Procedimiento para la preparacion de derivados de acidos n- (benzotiazol-2-il)-oxamidicos.

Info

Publication number
ES465034A1
ES465034A1 ES465034A ES465034A ES465034A1 ES 465034 A1 ES465034 A1 ES 465034A1 ES 465034 A ES465034 A ES 465034A ES 465034 A ES465034 A ES 465034A ES 465034 A1 ES465034 A1 ES 465034A1
Authority
ES
Spain
Prior art keywords
radical
preparation
group
r1r2r3
signify
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES465034A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of ES465034A1 publication Critical patent/ES465034A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Procedimiento para la preparación de derivados de ácidos N-(benzotiazol-2-il)-oxamídicos de la fórmula general I***(ver fórmula I)***En la que R1R2R3 y R4 significan hidrógenohalógenohidroxiloun radical feniloun radical alcohilo inferior de cadena recta o ramificada o un radical alcoxi inferiorel grupo nitro o el grupo trifluorometiloo R2 y R3 significan conjuntamente un grupo metilendioxiy X significa hidrógeno o un radical alcohilo inferiorno debiendo ser simultáneamente hidrógeno R1R2R3 y R4 en el caso de que X signifique un grupo etiloasí como de sus sales farmacológicamente compatibles.
ES465034A 1976-12-14 1977-12-14 Procedimiento para la preparacion de derivados de acidos n- (benzotiazol-2-il)-oxamidicos. Expired ES465034A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762656468 DE2656468A1 (de) 1976-12-14 1976-12-14 N-(benzthiazol-2-yl)-oxamidsaeure- derivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ES465034A1 true ES465034A1 (es) 1978-09-01

Family

ID=5995427

Family Applications (1)

Application Number Title Priority Date Filing Date
ES465034A Expired ES465034A1 (es) 1976-12-14 1977-12-14 Procedimiento para la preparacion de derivados de acidos n- (benzotiazol-2-il)-oxamidicos.

Country Status (17)

Country Link
JP (1) JPS5377058A (es)
AR (1) AR216496A1 (es)
AT (1) AT360523B (es)
AU (1) AU510730B2 (es)
BE (1) BE861794A (es)
CS (1) CS203179B2 (es)
DD (1) DD133329A5 (es)
DE (1) DE2656468A1 (es)
ES (1) ES465034A1 (es)
FI (1) FI57594C (es)
FR (1) FR2374317A1 (es)
GB (1) GB1538822A (es)
HU (1) HU175340B (es)
NL (1) NL7713580A (es)
SE (1) SE7714074L (es)
SU (1) SU680647A3 (es)
ZA (1) ZA777236B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2676775A (en) * 1949-10-24 1954-04-27 Gustav O Schulz Electric flatiron cord holder
DE3017976A1 (de) * 1980-05-10 1981-11-19 Dr. Karl Thomae Gmbh, 7950 Biberach Substituierte 2-amino-5-halogen-benzothiazole, verfahen zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4321372A (en) 1980-06-16 1982-03-23 Pfizer Inc. Antiulcer thiazol-2-ylcarbamoyl-carboxylic acids, esters and amides
DE3027527A1 (de) 1980-07-19 1982-02-18 Basf Ag, 6700 Ludwigshafen Neue oxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
GB2090826B (en) * 1981-01-09 1985-06-12 Usv Pharma Corp New heterocyclic compounds useful as anti-allergie agents
DE3135250A1 (de) * 1981-09-05 1983-03-17 Basf Ag, 6700 Ludwigshafen Tricyclische thiazolyloxamate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
US4826860A (en) * 1987-03-16 1989-05-02 Warner-Lambert Company Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents
FI91859C (fi) * 1987-06-17 1994-08-25 Eisai Co Ltd Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi
MXPA02012596A (es) 2000-06-21 2003-04-10 Hoffmann La Roche Derivados de benzotiazol.
US7087761B2 (en) 2003-01-07 2006-08-08 Hoffmann-La Roche Inc. Cyclization process for substituted benzothiazole derivatives
EA011279B1 (ru) 2004-05-24 2009-02-27 Ф. Хоффманн-Ля Рош Аг (4-метокси-7-морфолин-4-илбензотиазол-2-ил)-амид 4-гидрокси-4-метилпиперидин-1-карбоновой кислоты
CN101056857B (zh) 2004-11-05 2010-12-01 弗·哈夫曼-拉罗切有限公司 异烟酸衍生物的制备方法
CA2602444C (en) 2005-03-23 2013-03-19 F.Hoffmann-La Roche Ag Acetylenyl-pyrazolo-pyrimidine derivatives as mglur2 antagonists
KR101121292B1 (ko) 2005-09-27 2012-04-13 에프. 호프만-라 로슈 아게 Mglur2 길항제로서 옥사다이아졸일 피라졸로-피리미딘

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150140A (en) * 1976-12-23 1979-04-17 The Upjohn Company Benzothiazolyl oxanic acids, esters and salts

Also Published As

Publication number Publication date
ZA777236B (en) 1978-11-29
FR2374317A1 (fr) 1978-07-13
FR2374317B1 (es) 1980-11-07
NL7713580A (nl) 1978-06-16
AU510730B2 (en) 1980-07-10
AT360523B (de) 1981-01-12
FI57594B (fi) 1980-05-30
ATA890777A (de) 1980-06-15
HU175340B (hu) 1980-07-28
BE861794A (fr) 1978-06-13
DD133329A5 (de) 1978-12-27
FI773738A (fi) 1978-06-15
GB1538822A (en) 1979-01-24
FI57594C (fi) 1980-09-10
SE7714074L (sv) 1978-06-15
CS203179B2 (en) 1981-02-27
SU680647A3 (ru) 1979-08-15
AU3137777A (en) 1979-06-14
JPS5377058A (en) 1978-07-08
DE2656468A1 (de) 1978-06-15
AR216496A1 (es) 1979-12-28

Similar Documents

Publication Publication Date Title
ES465034A1 (es) Procedimiento para la preparacion de derivados de acidos n- (benzotiazol-2-il)-oxamidicos.
ES8705458A1 (es) Un procedimiento para la preparacion de un antibiotico de macrolida
IE44280L (en) 2,3-DIHYDRO-IMIDAZO [2,1-b] THIAZOLES HAVING ANALGESIC AND¹ANTI-INFLAMMATORY ACTIVITY
ES424483A1 (es) Procedimiento para la preparacion de compuestos heteroci- clicos sustituidos por un radical guanidilideno.
ES454086A1 (es) Procedimiento para la preparacion de n-(r-tetrahidrofurfu- ril)-noroximorfona y n-(s-tetrahidrofurfuril)-norosimorfona nuevas.
ES458176A1 (es) Procedimiento para la preparacion de derivados de indazolil-(4)-oxi-propanolamina.
ES432789A1 (es) Procedimiento para la preparacion de bencitaminas.
FR2336374A1 (fr) A-monoacetals de derives d'acides a,b-dioxo-carboxyliques, utilisables comme inducteurs de photopolymerisation
ES470108A1 (es) Procedimiento para preparar nuevos derivados de alcanolamina
ES440713A1 (es) Procedimiento para la preparacion de eteres y cetonas 2-car-balcociamino-bencimidazolil-5 (6)-fenilicos sustituidos con radicales basicos.
ES452391A1 (es) Procedimiento para la preparacion de nuevas arilalcohilami- nas sustituidas.
ES428600A1 (es) Procedimiento de preparacion de fenilpiperazino-1 amino-3 propanoles-2.
TR199701174T1 (xx) 1-$ w-(3,4-dihidro-2-naftalenil)alkil] sislik amin t�revleri, �retim prosesi ve bu t�revleri i�eren ila� terkipleri.
ES456048A1 (es) Procedimiento de preparacion de derivados de la piridoxina.
BR9815178A (pt) Autoimunosupressor e/ou potencializador mediado pelo aumento de células nkt, composto e processo para sua produção
ES472703A1 (es) Un procedimiento para preparar derivados del acido oxanilico
GB986644A (en) Novel derivatives of salicylic acid and preparations thereof
ES462599A1 (es) Procedimiento para la preparacion de derivados de acidos- 2-(fenil-alcohilhidrazono)-propionico.
ES398146A1 (es) Un procedimiento de preparacion de 4-amino - n,n- (dialco- hilalcohilendiamino) - benzamidas sustituidas en las posi- ciones 2 y 5.
ES453829A1 (es) Procedimiento de preparacion de quinazolinonas
ES466807A1 (es) Un procedimiento para la preparacion de una aminoverninomi- cina b, c o d sustituida en n o no sustituida en n
ES464164A1 (es) Procedimiento para la preparacion de 1-metil-2-(fenil-oxime-til)-5-nitro-imidazoles.
ES464165A1 (es) Procedimiento para la preparacion de 1-metil-2-(fenil-oxime-til)-5-nitro-imidazoles.
ES471735A1 (es) Procedimiento para la preparacion de derivados de acido fenilacetico
ES452926A1 (es) Procedimiento para la preparacion de 1-metil-2(-feniloxime- til-)5-nitrounidazoles.